GlassScriptPhysician profile
James William Erwin
NPI 1972542512
$561.06
in general payments reported to CMS, 2019-2025
10 companies · $18.33 in 2025
The $18.33 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.04 · 2020: $141 · 2021: $161 · 2022: $14.04 · 2023: $63.12 · 2024: $75.53 · 2025: $18.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $149.57 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $129.86 | 2019-2024 | Xarelto |
| Ucb, INC. | $63.34 | 2022-2023 | Nayzilam, Briviact |
| Astrazeneca Pharmaceuticals LP | $53.59 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $42.48 | 2020-2025 | Eliquis |
| Otsuka America Pharmaceutical, INC. | $40.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.04 | 2019-2024 | |
| Abbvie INC. | $17.29 | 2021 | |
| Mallinckrodt Hospital Products INC. | $14.61 | 2024 | Terlivaz |
| Mallinckrodt Enterprises LLC | $14.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Erwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.